All stock lists
Ovid Therapeutics Inc. (NASDAQ:OVID)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.17+0.01 (+0.23%)
Insider Score
––Not scored
OVID Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
OVID analyst forecast
OVID analyst consensus
No analyst ratings in the last 3 months.
OVID 12-month price target
$6.50+201.6% upsideaverage of 2 firms
$8.00High
$5.00Low
Best analysts covering OVID
No firm covering OVID has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
OVID analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| H.C. Wainwright | — | $5.00 | +90.1% | — | 2026-09-11 | |
| Roth Capital | — | $8.00 | +186.2% | — | 2026-09-03 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.